f C-Reactive Protein Velocity in Patients with ST-elevation Myocardial Infarction: Rethinking a Traditional Biomarker

References

1. Amezcua-CastilloE. González-PachecoH. Sáenz-San MartínA. Méndez-OcampoP. Gutierrez-MoctezumaI. MassóF. Sierra-LaraD. SpringallR. RodríguezE. Arias-MendozaA. Amezcua-GuerraL.M. C-reactive protein: The quintessential marker of systemic inflammation in coronary artery disease—advancing toward precision medicine.Biomedicines2023119244410.3390/biomedicines11092444 37760885
   [Google Scholar]
2. SuleimanM. KhatibR. AgmonY. MahamidR. BoulosM. KapeliovichM. LevyY. BeyarR. MarkiewiczW. HammermanH. AronsonD. Early inflammation and risk of long-term development of heart failure and mortality in survivors of acute myocardial infarction predictive role of C-reactive protein.J. Am. Coll. Cardiol.200647596296810.1016/j.jacc.2005.10.055 16516078
   [Google Scholar]
3. BlackS. KushnerI. SamolsD. C-reactive protein.J. Biol. Chem.200427947484874849010.1074/jbc.R400025200 15337754
   [Google Scholar]
4. LevinsonT. WassermanA. C-reactive protein velocity (CRPv) as a new biomarker for the early detection of acute infection/inflammation.Int. J. Mol. Sci.20222315810010.3390/ijms23158100 35897672
   [Google Scholar]
5. MilwidskyA. Ziv-BaranT. Letourneau-ShesafS. KerenG. TaiebP. BerlinerS. ShachamY. CRP velocity and short-term mortality in ST segment elevation myocardial infarction.Biomarkers2017223-438338610.1080/1354750X.2017.1279218 28055283
   [Google Scholar]
6. HolzknechtM. TillerC. ReindlM. LechnerI. FinkP. LungerP. MayrA. HenningerB. BrennerC. KlugG. BauerA. MetzlerB. ReinstadlerS.J. Association of C-reactive protein velocity with early left ventricular dysfunction in patients with first st-elevation myocardial infarction.J. Clin. Med.20211023549410.3390/jcm10235494 34884196
   [Google Scholar]
7. HolzknechtM. TillerC. ReindlM. LechnerI. TrogerF. HospM. MayrA. BrennerC. KlugG. BauerA. MetzlerB. ReinstadlerS.J. C-reactive protein velocity predicts microvascular pathology after acute ST-elevation myocardial infarction.Int. J. Cardiol.2021338303610.1016/j.ijcard.2021.06.023 34147553
   [Google Scholar]
8. ZahlerD. MerdlerI. RozenfeldK.L. ShenbergG. MilwidskyA. BerlinerS. BanaiS. ArbelY. ShachamY. C-reactive protein velocity and the risk of new onset atrial fibrillation among ST elevation myocardial infarction patients.Isr. Med. Assoc. J.2021233169173 33734630
   [Google Scholar]
9. ZahlerD. RozenfeldK.L. SteinM. MilwidskyA. BerlinerS. BanaiS. ArbelY. ShachamY. C-reactive protein velocity and the risk of acute kidney injury among ST elevation myocardial infarction patients undergoing primary percutaneous intervention.J. Nephrol.201932343744310.1007/s40620‑019‑00594‑2 30706372
   [Google Scholar]